The SARS-CoV-2 spike protein is vulnerable to moderate electric fields

Most of the ongoing projects aimed at the development of specific therapies and vaccines against COVID-19 use the SARS-CoV-2 spike (S) protein as the main target. The binding of the spike protein with the ACE2 receptor (ACE2) of the host cell constitutes the first and key step for virus entry. Durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbeitman, Claudia R., Rojas, Pablo, Ojeda-May, Pedro, Garcia, Martin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437970/
https://www.ncbi.nlm.nih.gov/pubmed/34518528
http://dx.doi.org/10.1038/s41467-021-25478-7

Ejemplares similares

Ejemplares similares